Allianz Asset Management GmbH - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$501,417
+17.9%
14,7000.0%0.00%0.0%
Q4 2023$425,418
+5.0%
14,7000.0%0.00%0.0%
Q3 2023$405,279
-8.3%
14,7000.0%0.00%0.0%
Q2 2023$441,882
-90.8%
14,700
-89.3%
0.00%
-80.0%
Q1 2019$4,809,000
+44.8%
137,241
+37.3%
0.01%
+25.0%
Q4 2018$3,321,000
-66.7%
99,970
-49.5%
0.00%
-55.6%
Q3 2018$9,970,000
-2.5%
198,022
+15.9%
0.01%
-10.0%
Q2 2018$10,223,000
-19.9%
170,817
-38.7%
0.01%
-16.7%
Q1 2018$12,765,000
+84.3%
278,701
+60.3%
0.01%
+140.0%
Q4 2017$6,928,000
+9.9%
173,872
+10.3%
0.01%0.0%
Q3 2017$6,305,000
-55.9%
157,621
-52.5%
0.01%
-64.3%
Q2 2017$14,282,000
-15.7%
331,742
-38.7%
0.01%
-17.6%
Q1 2017$16,938,000
+28.4%
541,158
+3.6%
0.02%
+41.7%
Q4 2016$13,188,000
-10.7%
522,300
-12.6%
0.01%
-14.3%
Q3 2016$14,771,000
+93.2%
597,281
+59.1%
0.01%
+75.0%
Q2 2016$7,647,000
-23.4%
375,424
-42.7%
0.01%
-27.3%
Q1 2016$9,985,000
+13.2%
654,740
-0.2%
0.01%
+10.0%
Q4 2015$8,818,000
-4.2%
656,116
-0.0%
0.01%
-9.1%
Q3 2015$9,206,000
-15.9%
656,145
+1.8%
0.01%
-8.3%
Q2 2015$10,941,000
+300.6%
644,347
+185.3%
0.01%
+300.0%
Q1 2015$2,731,000
+51.1%
225,862
+3.7%
0.00%
+50.0%
Q4 2014$1,808,000
+1.3%
217,838
+6.1%
0.00%0.0%
Q3 2014$1,784,000
-26.4%
205,277
-7.2%
0.00%
-33.3%
Q2 2014$2,423,000221,3000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders